Preclinical compounds intended to alter energy expenditure or reproduce selected molecular responses to exercise.
The “exercise pill” headline compresses complex animal research into an easy consumer promise.
Pathway activation is not equivalent to the cardiovascular, neurological, musculoskeletal and functional effects of training.
Watch for human safety data before discussing efficacy; BAM15 is named on the 2026 WADA list.